RCT to Evaluate the Efficacy & Safety of Ivy Leaves Cough Liquid vs.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

See also
Status	Clinical Trial	Phase
Completed	`NCT00547846` - A Phase II Clinical Study of PDC-748 in Patients With Acute Cough	Phase 2
Completed	`NCT01597349` - Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection	Phase 2
Terminated	`NCT03569033` - Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)	Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT00547846 - A Phase II Clinical Study of PDC-748 in Patients With Acute Cough

Phase 2

Completed

NCT01597349 - Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection

Phase 2

Terminated

NCT03569033 - Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02396706
Study type	Interventional
Source	Engelhard Arzneimittel GmbH & Co.KG
Contact
Status	Completed
Phase	Phase 2
Start date	January 2015
Completion date	June 2015

RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms